159992 创新药
已收盘 07-25 15:00:00
资讯
新帖
简况
新天药业:中药创新药研发进展披露
证券之星 · 08:12
新天药业:中药创新药研发进展披露
千金药业:公司目前有5个创新药在研,其中3个中药1类新药
互动易 · 07:54
千金药业:公司目前有5个创新药在研,其中3个中药1类新药
海正药业:海博麦布片系公司第一个1类创新药
证券之星 · 07:37
海正药业:海博麦布片系公司第一个1类创新药
医药板块也“反内卷”!CXO、医疗器械接棒反攻,创新药ETF天弘(517380)、医疗设备ETF(159873)涨超1%
格隆汇 · 02:24
医药板块也“反内卷”!CXO、医疗器械接棒反攻,创新药ETF天弘(517380)、医疗设备ETF(159873)涨超1%
5款创新药纳入突破性疗法,来自宝济药业、泽璟制药等
制药网 · 02:18
5款创新药纳入突破性疗法,来自宝济药业、泽璟制药等
收涨100%!这家0收入创新药企要火
中国基金报 · 07-24 15:02
收涨100%!这家0收入创新药企要火
研报掘金丨中泰证券:维持康弘药业“买入”评级,眼科龙头守正出奇
格隆汇 · 07-24 08:07
研报掘金丨中泰证券:维持康弘药业“买入”评级,眼科龙头守正出奇
港股异动 | 思派健康(00314.HK)午后涨超10% 超百款药品申报商保创新药目录 公司深度聚焦商业医疗保险业务
智通财经 · 07-24 06:49
港股异动 | 思派健康(00314.HK)午后涨超10% 超百款药品申报商保创新药目录 公司深度聚焦商业医疗保险业务
港股异动 | 思派健康(00314)午后涨超10% 超百款药品申报商保创新药目录 公司深度聚焦商业医疗保险业务
智通财经 · 07-24 06:49
港股异动 | 思派健康(00314)午后涨超10% 超百款药品申报商保创新药目录 公司深度聚焦商业医疗保险业务
康方生物(09926)涨超6% 核心产品依沃西有新进展 机构指公司创新药产品疗效优秀
金吾财讯 · 07-24 06:13
康方生物(09926)涨超6% 核心产品依沃西有新进展 机构指公司创新药产品疗效优秀
A股创新药概念延续强势,亚宝药业涨停,键凯科技、汉商集团、悦康药业、哈三联、海特生物等涨幅居前
华尔街见闻 · 07-24 01:35
A股创新药概念延续强势,亚宝药业涨停,键凯科技、汉商集团、悦康药业、哈三联、海特生物等涨幅居前
诺诚健华-U股价下跌4.25% 创新药板块获基金经理关注
金融界 · 07-23 19:25
诺诚健华-U股价下跌4.25% 创新药板块获基金经理关注
国家药监局:我国上半年批准创新药43个 同比增长59%
金吾财讯 · 07-23 08:25
国家药监局:我国上半年批准创新药43个 同比增长59%
汉邦科技:公司作为制药装备生产提供商促进创新药发展
证券之星 · 07-23 07:33
汉邦科技:公司作为制药装备生产提供商促进创新药发展
【科创板收评】盘面冲高回落,科创50收涨0.45%,创新药机器人走势分化
犀牛之星 · 07-23 07:20
【科创板收评】盘面冲高回落,科创50收涨0.45%,创新药机器人走势分化
创新药概念再度活跃 塞力医疗涨停
E公司 · 07-23 01:55
创新药概念再度活跃 塞力医疗涨停
君实生物-U中标创新药引进项目 助力药品销售业务增长
自选股中标信息 · 07-22
君实生物-U中标创新药引进项目 助力药品销售业务增长
基金南下抢筹 港股银行和创新药最受青睐!
券商中国 · 07-22
基金南下抢筹 港股银行和创新药最受青睐!
港股异动 | 同源康医药-B(02410)尾盘急升逾7% 旗下三款创新药研究成果获ESMO 2025收录
智通财经 · 07-22
港股异动 | 同源康医药-B(02410)尾盘急升逾7% 旗下三款创新药研究成果获ESMO 2025收录
键凯科技:创新药伊立替康有三个临床试验适应症
证券之星 · 07-22
键凯科技:创新药伊立替康有三个临床试验适应症
加载更多
公司概况
公司名称:
--
所属市场:
上市日期:
--
主营业务:
发行价格:
--
{"stockData":{"symbol":"159992","market":"SZ","secType":"STK","nameCN":"创新药","latestPrice":0.889,"timestamp":1753427028000,"preClose":0.895,"halted":0,"volume":477661600,"delay":0,"changeRate":-0.0067,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":-0.006,"latestTime":"07-25 15:00:00","open":0.894,"high":0.904,"low":0.886,"amount":427000000,"amplitude":0.0201,"askPrice":0.889,"askSize":3398,"bidPrice":0.888,"bidSize":5829,"shortable":0,"etf":1,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753666200000},"marketStatusCode":5,"adr":0,"adjPreClose":0.895,"symbolType":"fund","openAndCloseTimeList":[[1753407000000,1753414200000],[1753419600000,1753426800000]],"highLimit":0.985,"lowLimit":0.806,"ibTradeSell":false,"ibTradeBuySell":true,"isCdr":false,"pbRate":0,"committee":0.766858,"marketValue":0,"turnoverRate":0,"status":1,"floatMarketCap":0},"requestUrl":"/m/hq/s/159992","defaultTab":"news","newsList":[{"id":"2554752925","title":"新天药业:中药创新药研发进展披露","url":"https://stock-news.laohu8.com/highlight/detail?id=2554752925","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554752925?lang=zh_cn&edition=full","pubTime":"2025-07-25 16:12","pubTimestamp":1753431135,"startTime":"0","endTime":"0","summary":"证券之星消息,新天药业07月25日在投资者关系平台上答复投资者关心的问题。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072500024822.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","159992","002873","BK0239","BK1574","06978"],"gpt_icon":0},{"id":"2554752116","title":"千金药业:公司目前有5个创新药在研,其中3个中药1类新药","url":"https://stock-news.laohu8.com/highlight/detail?id=2554752116","media":"互动易","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554752116?lang=zh_cn&edition=full","pubTime":"2025-07-25 15:54","pubTimestamp":1753430041,"startTime":"0","endTime":"0","summary":"有投资者向千金药业提问, 近期创新药板块市场表现不错?贵司年报显示25年加大研发,目前贵司创新药进展如何?公司回答表示,感谢关注。公司目前有5个创新药在研,其中3个中药1类新药:1个已进入临床阶段,2个处于药学研究阶段,2个化药创新药均处于化合物筛选阶段。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725160902a6c13d7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725160902a6c13d7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159992","561510","600479","BK0239","562390","BK0186"],"gpt_icon":0},{"id":"2554754610","title":"海正药业:海博麦布片系公司第一个1类创新药","url":"https://stock-news.laohu8.com/highlight/detail?id=2554754610","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554754610?lang=zh_cn&edition=full","pubTime":"2025-07-25 15:37","pubTimestamp":1753429043,"startTime":"0","endTime":"0","summary":"证券之星消息,海正药业07月25日在投资者关系平台上答复投资者关心的问题。或者介绍下重要参股公司“博锐生物”的新药情况。公司产品海博麦布片系公司第一个1类创新药,其成功获批进一步丰富了公司产品线,有助于提升公司产品的市场竞争力;博锐生物具有20+主要在研产品,其中10+已进入临床和7个商业化上市产品+1个授权商业化推广产品。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072500020609.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600267","BK0188","BK0028","159992","BK1161","BK0239","BK1574","BK0060","06978"],"gpt_icon":0},{"id":"2554773796","title":"医药板块也“反内卷”!CXO、医疗器械接棒反攻,创新药ETF天弘(517380)、医疗设备ETF(159873)涨超1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554773796","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554773796?lang=zh_cn&edition=full","pubTime":"2025-07-25 10:24","pubTimestamp":1753410246,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["601788","159873","159399","399300","600196","06978","159646","159992","512290","09997","03759","159883","159982","09939","HSTECH","06178","161726","515120","688271","BK0060","FDN","399441","300832","HSCEI","159938","163118","LU0979878070.USD","159645","300759","CXO.AU","CXO","06127","300760","603976","BK1515","159859","YANG","159217","09996","07226","159891","300122","000808.SH","688626","300869","603127","02196","02269"],"gpt_icon":0},{"id":"2554737477","title":"5款创新药纳入突破性疗法,来自宝济药业、泽璟制药等","url":"https://stock-news.laohu8.com/highlight/detail?id=2554737477","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554737477?lang=zh_cn&edition=full","pubTime":"2025-07-25 10:18","pubTimestamp":1753409939,"startTime":"0","endTime":"0","summary":"根据国家药品监督管理局药品审评中心网站公示,7月以来,已有多款创新药纳入突破性疗法。如7月25日,上海宝济药业股份有限公司注射用KJ103纳入突破性疗法,拟用于抗肾小球基底膜病。资料显示,KJ103是新一代IgG降解酶,它来源于不感染人类的化脓性链球菌的酶,通过宝济药业自主研发设计改构而获得。ZG006 在非人灵长类动物中显示出毒副作用低等良好的安全性特征。业内表示,这几款创新药纳入突破性治疗品种,是医药研发领域的重大进展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725102217971d44ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725102217971d44ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688266","159992"],"gpt_icon":0},{"id":"2554334347","title":"收涨100%!这家0收入创新药企要火","url":"https://stock-news.laohu8.com/highlight/detail?id=2554334347","media":"中国基金报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554334347?lang=zh_cn&edition=full","pubTime":"2025-07-24 23:02","pubTimestamp":1753369320,"startTime":"0","endTime":"0","summary":"【导读】明日即将在港股挂牌上市的维立志博暗盘交易大涨100.14%在港股创新药的大行情下,目前0收入且亏损的维立志博获得港股市场追捧。利弗莫尔证券暗盘交易显示,截至收盘,将于7月25日( ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20250724/c669889415.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20250724/c669889415.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["159992"],"gpt_icon":0},{"id":"2553272025","title":"研报掘金丨中泰证券:维持康弘药业“买入”评级,眼科龙头守正出奇","url":"https://stock-news.laohu8.com/highlight/detail?id=2553272025","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553272025?lang=zh_cn&edition=full","pubTime":"2025-07-24 16:07","pubTimestamp":1753344420,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0276","06978","159992","BK0197","BK4231","002773","BK0196","BK1574","600918","BK0239","BK1161","BK4080","ADC"],"gpt_icon":0},{"id":"2553271567","title":"港股异动 | 思派健康(00314.HK)午后涨超10% 超百款药品申报商保创新药目录 公司深度聚焦商业医疗保险业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2553271567","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553271567?lang=zh_cn&edition=full","pubTime":"2025-07-24 14:49","pubTimestamp":1753339769,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","BK1247","00314","06978","BK1574","159992"],"gpt_icon":0},{"id":"2553271560","title":"港股异动 | 思派健康(00314)午后涨超10% 超百款药品申报商保创新药目录 公司深度聚焦商业医疗保险业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2553271560","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553271560?lang=zh_cn&edition=full","pubTime":"2025-07-24 14:49","pubTimestamp":1753339769,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,思派健康午后涨超10%,截至发稿,涨9.03%,报6.76港元,成交额9775.01万港元。目前一共有超过100个药品申报了创新药目录,接下来国家医保局会按程序做好后续工作。据悉,4月24日,复星联合健康保险与思派健康在上海正式签署战略合作协议。6月26日,思派健康与国际保险服务集团安睿嘉尔签订战略合作协议。此外,随着商业医疗保险渗透率提升和创新药市场扩容,公司独特的生态闭环价值有望获得更充分定价。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1321435.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","159992","00314","BK1574","BK1247","06978"],"gpt_icon":0},{"id":"2553279810","title":"康方生物(09926)涨超6% 核心产品依沃西有新进展 机构指公司创新药产品疗效优秀","url":"https://stock-news.laohu8.com/highlight/detail?id=2553279810","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553279810?lang=zh_cn&edition=full","pubTime":"2025-07-24 14:13","pubTimestamp":1753337599,"startTime":"0","endTime":"0","summary":"金吾财讯 | 康方生物 午后发力走高,截至发稿,报152.4港元,涨幅6.28%,成交额15.32亿港元。依沃西联合化疗联合/不联合莱法利有望填补治疗转移性胰腺癌一线免疫疗法的空白。中信建投研报指,康方生物作为全球双抗引领者,其核心产品依沃西成为全球首个在1L肺癌治疗中mPFS超越K药的双抗,海外HARMONi数据延续国内获益趋势,验证了依沃西在跨区域研究中具有一致性的临床疗效。考虑到公司创新药产品疗效优秀、市场空间广阔,给予“买入”评级。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1962814","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348784397.USD","159992","IE00BPRC5H50.USD","BK1574","LU1794554557.SGD","BK1161","06978","LU0417516571.SGD","IE00B543WZ88.USD","LU0348783233.USD","LU1720050803.USD","09926","LU2488822045.USD","IE00B5MMRT66.SGD"],"gpt_icon":0},{"id":"2553222660","title":"A股创新药概念延续强势,亚宝药业涨停,键凯科技、汉商集团、悦康药业、哈三联、海特生物等涨幅居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2553222660","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553222660?lang=zh_cn&edition=full","pubTime":"2025-07-24 09:35","pubTimestamp":1753320947,"startTime":"0","endTime":"0","summary":"A股 创新药 概念延续强势, 亚宝药业 涨停, 键凯科技 、 汉商集团 、 悦康药业 、 哈三联 、 海特生物 等涨幅居前。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724095832a6be9229&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724095832a6be9229&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["399300","BK0229","600351","159992","600774","159982","BK0077","002900","BK0096","BK0028","688356","300683","BK0201","BK0239","688658","BK0209"],"gpt_icon":0},{"id":"2553247496","title":"诺诚健华-U股价下跌4.25% 创新药板块获基金经理关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2553247496","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553247496?lang=zh_cn&edition=full","pubTime":"2025-07-24 03:25","pubTimestamp":1753298737,"startTime":"0","endTime":"0","summary":"截至2025年7月23日15时,诺诚健华-U股价报30.22元,较前一交易日下跌1.34元,跌幅4.25%。当日开盘价为31.15元,最高触及31.58元,最低下探至30.14元,成交量为8.65万手,成交额达2.66亿元。诺诚健华-U属于生物制品和创新药板块,专注于肿瘤及自身免疫性疾病领域的创新药物研发。部分基金经理在二季度加大了对创新药板块的配置。数据显示,诺诚健华-U当日主力资金净流出595.32万元,占流通市值的0.07%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724033050954f456d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724033050954f456d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159992","BK0239","688428"],"gpt_icon":0},{"id":"2553929010","title":"国家药监局:我国上半年批准创新药43个 同比增长59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553929010","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553929010?lang=zh_cn&edition=full","pubTime":"2025-07-23 16:25","pubTimestamp":1753259127,"startTime":"0","endTime":"0","summary":"金吾财讯 | 据央视新闻报道,国家药监局统计显示,我国上半年批准创新药43个,同比增长59%,接近2024年批准创新药48个的全年数量。国家药监局药品注册管理司司长杨霆表示,其中有很多都是肿瘤、代谢和免疫等重大疾病治疗的药物,比如批准了国内首款基因治疗产品,用于血友病B基因治疗,另外还批准了一个罕见病的药物用于免疫代谢疾病的治疗。","market":"us","thumbnail":"https://static.szfiu.com/news/20250106/MjZkYzRkZGZiMTdhMWMxODRmMmVmOWU4NjgwNzkyNjczOTk=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/MjZkYzRkZGZiMTdhMWMxODRmMmVmOWU4NjgwNzkyNjczOTk=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1962746","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","06978","BK1574","BK1161"],"gpt_icon":0},{"id":"2553926452","title":"汉邦科技:公司作为制药装备生产提供商促进创新药发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2553926452","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553926452?lang=zh_cn&edition=full","pubTime":"2025-07-23 15:33","pubTimestamp":1753256010,"startTime":"0","endTime":"0","summary":"随着创新药物的研发加速,纯化环节在药物生产过程中的重要性愈发显著,市场对于高质量制药装备以及创新药物生产解决方案的需求将持续攀升。公司作为制药装备生产提供商,将紧跟创新生物药及化学药物研发生产的发展步伐,积极满足相关需求,努力为创新药药物的发展贡献更多力量。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072300021177.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06978","01477","BK1574","688755","BK0251","BK1191","159992","BK1161"],"gpt_icon":0},{"id":"2553290286","title":"【科创板收评】盘面冲高回落,科创50收涨0.45%,创新药机器人走势分化","url":"https://stock-news.laohu8.com/highlight/detail?id=2553290286","media":"犀牛之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553290286?lang=zh_cn&edition=full","pubTime":"2025-07-23 15:20","pubTimestamp":1753255200,"startTime":"0","endTime":"0","summary":"犀牛之星7月23日讯,今日科创板早间震荡拉升,午后震荡回落,科创50收涨0.45%,报1020.86点。截至当日收市,共227只个股收涨,353只个股收跌。跌幅排行方面,新锐股份 跌10.31%居首,华强科技跌6.58%次之。成交额方面,科创板全天共成交1345.36亿元,寒武纪 成交32.37亿元居首,中微公司 成交31.33亿元次之。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072315412197b20234&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072315412197b20234&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159982","000688.SH","000688","159992","BK0242"],"gpt_icon":0},{"id":"2553326066","title":"创新药概念再度活跃 塞力医疗涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2553326066","media":"E公司","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553326066?lang=zh_cn&edition=full","pubTime":"2025-07-23 09:55","pubTimestamp":1753235703,"startTime":"0","endTime":"0","summary":"人民财讯7月23日电,创新药概念再度活跃,截至发稿,塞力医疗涨停,三元基因、美迪西、普蕊斯、亚太药业等跟涨。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723095503954dd94c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723095503954dd94c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159992","BK0250","BK0216","603716","688202"],"gpt_icon":0},{"id":"2553230449","title":"君实生物-U中标创新药引进项目 助力药品销售业务增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2553230449","media":"自选股中标信息","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553230449?lang=zh_cn&edition=full","pubTime":"2025-07-22 19:08","pubTimestamp":1753182499,"startTime":"0","endTime":"0","summary":"2025年07月22日,据天眼查数据,四川省成都市温江区人民医院创新药引进公示(四)显示,中标方为君实生物-U,招标方为成都市温江区人民医院。近半年内,君实生物-U获得1家券商积极评价:太平洋证券给予\"买入\"评级。君实生物-U主营业务涵盖药品销售,技术许可及特许权使用收入,其他收入之和。截至发稿,君实生物-U股价报39.29元,上涨1.79%,成交额至7.27亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722190829a45c36da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722190829a45c36da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159992","BK0239","688180"],"gpt_icon":0},{"id":"2553336562","title":"基金南下抢筹 港股银行和创新药最受青睐!","url":"https://stock-news.laohu8.com/highlight/detail?id=2553336562","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553336562?lang=zh_cn&edition=full","pubTime":"2025-07-22 15:58","pubTimestamp":1753171138,"startTime":"0","endTime":"0","summary":"今年以来,港股强势反攻,公募基金南下抢筹的趋势越来越明显。最新披露的公募基金2025年二季报显示,全市场有近1800只基金在二季度提高了港股仓位,部分基金的增持幅度超过50个百分点,以创新药为代表的高成长方向,和以银行股为代表的高股息方向,成为基金加仓港股的两大“心头好”。近1800只基金提高港股仓位从基金二季报来看,可投资港股的港股通基金、QDII基金普遍提高了港股仓位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/news/1354,202507223464111388.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"eastmoney_highlight","symbols":["BK1574","06978","YANG","HSTECH","BK1161","159992","BK4614","HSCEI","161121"],"gpt_icon":1},{"id":"2553238896","title":"港股异动 | 同源康医药-B(02410)尾盘急升逾7% 旗下三款创新药研究成果获ESMO 2025收录","url":"https://stock-news.laohu8.com/highlight/detail?id=2553238896","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553238896?lang=zh_cn&edition=full","pubTime":"2025-07-22 15:49","pubTimestamp":1753170580,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,同源康医药-B尾盘急升逾7%,截至发稿,涨5.53%,报19.08港元,成交额6276.81万港元。消息面上,同源康医药今日宣布,公司自主研发的三款创新药物——CDK2/4抑制剂TY-00540、CDK7抑制剂TY-2699a及CDK4/6抑制剂TY-302的I期临床试验结果,正式获2025年欧洲肿瘤内科学会大会以壁报形式收录。此外,同源康医药6月9日正式获纳入恒生生物科技指数成份股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1320514.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06978","02410","BK1515","159938","159992","09939","BK1161","BK1574"],"gpt_icon":0},{"id":"2553280527","title":"键凯科技:创新药伊立替康有三个临床试验适应症","url":"https://stock-news.laohu8.com/highlight/detail?id=2553280527","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553280527?lang=zh_cn&edition=full","pubTime":"2025-07-22 15:37","pubTimestamp":1753169828,"startTime":"0","endTime":"0","summary":"证券之星消息,键凯科技07月22日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司在创新药领域,是否布局了10多个管线?包含一个临床三期?目前公司的创新药项目伊立替康有三个处于临床试验的适应症:小细胞肺癌适应症处于Ⅲ期临床试验,伴脑转移的乳腺癌适应症和脑胶质瘤适应症处于Ⅱ期临床试验。再次感谢您对键凯科技的关注。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072200019903.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","159992","BK1576","BK1161","688356","BK1141","06978","BK1583","BK1574","03347"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1753448891970,"stockEarnings":[{"period":"1week","weight":0.0287},{"period":"1month","weight":0.1315},{"period":"3month","weight":0.2396},{"period":"6month","weight":0.3201},{"period":"1year","weight":0.4672},{"period":"ytd","weight":0.2841}],"compareEarnings":[{"period":"1week","weight":0.0253},{"period":"1month","weight":0.0541},{"period":"3month","weight":0.0943},{"period":"6month","weight":0.1086},{"period":"1year","weight":0.2425},{"period":"ytd","weight":0.0758}],"compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"创新药(159992)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供创新药(159992)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"创新药,159992,创新药股票,创新药股票老虎,创新药股票老虎国际,创新药行情,创新药股票行情,创新药股价,创新药股市,创新药股票价格,创新药股票交易,创新药股票购买,创新药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"创新药(159992)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供创新药(159992)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}